LigaChem Biosciences Inc. (141080.KQ)
LigaChem Biosciences Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs.
87,500.00+0.12%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago-31.2%
The outlook
LigaChem Biosciences Inc. currently reads as neutral based on buy — 1.7 avg of 6 analysts, below its 50- & 200-day averages, 7% of the way from its 52-week low to high, avg target +153% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Analyst consensusBuy — 1.7 avg of 6 analysts
Price trendBelow its 50- & 200-day averages
52-week range7% of the way from its 52-week low to high
Price targetAvg target +153% vs current price
Analyst price target
~12-month · 6 analysts221,666.67average target+153.3% vs now
Now 87,500.00
Low 200,000.00High 230,000.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$3.19T
52-wk high
225,000.00
52-wk low
76,900.00
50-day avg
129,258.00
200-day avg
166,024.00
Trailing P/E
—